102 related articles for article (PubMed ID: 1722364)
1. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus.
Solimena M; De Camilli P
Trends Neurosci; 1991 Oct; 14(10):452-7. PubMed ID: 1722364
[TBL] [Abstract][Full Text] [Related]
2. Neurological Manifestations of Glutamic Acid Decarboxylase Autoimmunity in Indian Patients.
Thevarkalam M; Kannoth S; Nambiar V; Gopinath S; Mathai A; Anandakuttan A; Krishnan S; Bhaskaran R
Ann Indian Acad Neurol; 2023; 26(5):663-671. PubMed ID: 38022450
[TBL] [Abstract][Full Text] [Related]
3. Case report: Approaches to treatment-refractory and super-refractory glutamic acid decarboxylase antibody-spectrum disorders.
Rajmohan R; Baveja S; Nguyen D; Shah E; Sy M; Attaripour S; Swope D
Front Immunol; 2023; 14():1297340. PubMed ID: 38259445
[TBL] [Abstract][Full Text] [Related]
4. Stiff hands in a man with type 1 diabetes.
Ahuja R; Pragya P
Cleve Clin J Med; 2023 Dec; 90(12):721-722. PubMed ID: 38040439
[No Abstract] [Full Text] [Related]
5. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
[TBL] [Abstract][Full Text] [Related]
6. Cofactor-dependent conformational heterogeneity of GAD65 and its role in autoimmunity and neurotransmitter homeostasis.
Kass I; Hoke DE; Costa MG; Reboul CF; Porebski BT; Cowieson NP; Leh H; Pennacchietti E; McCoey J; Kleifeld O; Borri Voltattorni C; Langley D; Roome B; Mackay IR; Christ D; Perahia D; Buckle M; Paiardini A; De Biase D; Buckle AM
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):E2524-9. PubMed ID: 24927554
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.
Solimena M; Folli F; Denis-Donini S; Comi GC; Pozza G; De Camilli P; Vicari AM
N Engl J Med; 1988 Apr; 318(16):1012-20. PubMed ID: 3281011
[TBL] [Abstract][Full Text] [Related]
8. Immunology of stiff person syndrome and other GAD-associated neurological disorders.
Alexopoulos H; Dalakas MC
Expert Rev Clin Immunol; 2013 Nov; 9(11):1043-53. PubMed ID: 24168411
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
11. Stiff Person Syndrome and Type 1 Diabetes Mellitus: a Case of the Chicken or the Egg?
Rathbun JT; Imber J
J Gen Intern Med; 2019 Jun; 34(6):1053-1057. PubMed ID: 30783882
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
13. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
14. An update on malignant tumor-related stiff person syndrome spectrum disorders: clinical mechanism, treatment, and outcomes.
Peng Y; Yang H; Xue YH; Chen Q; Jin H; Liu S; Yao SY; Du MQ
Front Neurol; 2023; 14():1209302. PubMed ID: 37859648
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, Clinical Profiles, and Prognosis of Stiff-Person Syndrome in a Japanese Nationwide Survey.
Matsui N; Tanaka K; Ishida M; Yamamoto Y; Matsubara Y; Saika R; Iizuka T; Nakamura K; Kuriyama N; Matsui M; Arisawa K; Nakamura Y; Kaji R; Kuwabara S; Izumi Y;
Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37739810
[TBL] [Abstract][Full Text] [Related]
16. Elevated IL-6 plasma levels are associated with GAD antibodies-associated autoimmune epilepsy.
Basnyat P; Peltola M; Raitanen J; Liimatainen S; Rainesalo S; Pesu M; Peltola J
Front Cell Neurosci; 2023; 17():1129907. PubMed ID: 37025699
[TBL] [Abstract][Full Text] [Related]
17. Involuntary movement in stiff-person syndrome with amphiphysin antibodies: A case report.
Xie YY; Meng HM; Zhang FX; Maimaiti B; Jiang T; Yang Y
Medicine (Baltimore); 2021 Jan; 100(3):e24312. PubMed ID: 33546061
[TBL] [Abstract][Full Text] [Related]
18. GAD antibodies in neurological disorders - insights and challenges.
Graus F; Saiz A; Dalmau J
Nat Rev Neurol; 2020 Jul; 16(7):353-365. PubMed ID: 32457440
[TBL] [Abstract][Full Text] [Related]
19. Neurological Syndromes Associated with Anti-GAD Antibodies.
Dade M; Berzero G; Izquierdo C; Giry M; Benazra M; Delattre JY; Psimaras D; Alentorn A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456344
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
